Advanced search
Publication Cover
Emerging Microbes & Infections Volume 10, 2021 - Issue 1
Submit an article Journal homepage
7,433
Views
26
CrossRef citations to date
0
Altmetric
Coronaviruses

Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial

Yuyi Liaoa Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Yuan Lia Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Rongjuan Peid Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Xin Fangc National Institutes for Food and Drug Control, Beijing, People’s Republic of ChinaView further author information
,
Peiyu Zenge Gaozhou Center for Disease Control and Prevention, Maoming, People’s Republic of ChinaView further author information
,
Renfeng Fana Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Zhiqiang Oua Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaView further author information
,
Jinglong Denge Gaozhou Center for Disease Control and Prevention, Maoming, People’s Republic of ChinaView further author information
,
Jian Zhoue Gaozhou Center for Disease Control and Prevention, Maoming, People’s Republic of ChinaView further author information
,
Wuxiang Guand Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Yuanqin Mind Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Fei Dengd Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
,
Hua Pengg Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People’s Republic of ChinaView further author information
,
Zheng Zhangh Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People’s Hospital, Shenzhen, People’s Republic of ChinaView further author information
,
Chunyan Fengf LivzonBio Inc., Zhuhai, People’s Republic of ChinaView further author information
,
Baobao Xinf LivzonBio Inc., Zhuhai, People’s Republic of ChinaView further author information
,
Jianfeng Heb Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Zhongyu Huc National Institutes for Food and Drug Control, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Jikai Zhanga Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1589-1597 | Received 11 Jun 2021, Accepted 29 Jun 2021, Published online: 12 Aug 2021

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xuan-Yi Wang, Syed Faisal Mahmood, Fang Jin, Wee Kooi Cheah, Muhammad Ahmad, Mian Amjad Sohail, Waheed Ahmad, Vijaya K. Suppan, Muneeba Ahsan Sayeed, Shobha Luxmi, Aik-Howe Teo, Li Yuan Lee, Yang-Yang Qi, Rong-Juan Pei, Wei Deng, Zhong-Hui Xu, Jia-Ming Yang, Yan Zhang, Wu-Xiang Guan & Xiong Yu. (2022) Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial. Emerging Microbes & Infections 11:1, pages 1910-1919.
Read now
Natalina Sutton, Alberto San Francisco Ramos, Emily Beales, David Smith, Sabina Ikram, Eva Galiza, Yingfen Hsia & Paul T. Heath. (2022) Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis. Expert Review of Vaccines 21:9, pages 1301-1318.
Read now

Articles from other publishers (24)

David A. González-Martínez, Gustavo González Ruíz, Cesar Escalante-Bermúdez, Judey Aymed García Artalejo, Tania Gómez Peña, José Alberto Gómez, Eduardo González-Martínez, Yadira Cazañas Quintana, Thais Fundora Barrios, Tays Hernández, Roberto Carlos Varela Pérez, Dayli Díaz Goire, Diaselys Castro López, Ingrid Ruíz Ramirez, Carlos R. Díaz-Águila & Jose M. Moran-Mirabal. (2023) Efficient capture of recombinant SARS-CoV-2 receptor-binding domain (RBD) with citrate-coated magnetic iron oxide nanoparticles. Nanoscale 15:17, pages 7854-7869.
Crossref
Yahya Ehteshaminia, Seyedeh Farzaneh Jalali, Farhad Jadidi-Niaragh, Seyed Ehsan Enderami, Abdol Sattar Pagheh, Esmaeil Akbari, Saeid Abedian Kenari & Hadi Hassannia. (2023) Enhancement of immunogenicity and neutralizing responses against SARS-CoV-2 spike protein using the Fc fusion fragment. Life Sciences 320, pages 121525.
Crossref
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, Shokouh Rezaei, Vuk Uskoković, Mahdi Alijanianzadeh, Vladimir N. Uversky, Seyed Omid Ranaei Siadat, Sina Mozaffari-Jovin & Yahya Sefidbakht. (2023) An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. Progress in Biophysics and Molecular Biology 178, pages 32-49.
Crossref
Masoud Solaymani Dodaran, Seyed Reza Banihashemi, Ali Es-haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Ladan Mokhberalsafa, Fariba Sadeghi, Alireza Ranjbar, Akram Ansarifar, Arash Mohazzab, Seyed Amin Setarehdan, Fahimeh Bagheri Amiri, Vahideh Mohseni, Monireh Hajimoradi, Neda Ghahremanzadeh, Seyed Hossein Razzaz, Safdar Masoomi, Maryam Taghdiri, Mohsen Bagheri, Mohsen Lofti, Akbar Khorasani, Masoud Ghader, Shiva Safari, Masumeh Shahsavn & Saeed Kalantari. (2023) Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial. Vaccines 11:2, pages 455.
Crossref
Jianzhong Zhang, Yutian Xia, Xuan Liu & Gang Liu. (2023) Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants. Bioengineering 10:2, pages 148.
Crossref
Angelina Kovalenko, Ekaterina Ryabchevskaya, Ekaterina Evtushenko, Nikolai Nikitin & Olga Karpova. (2023) Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress. International Journal of Molecular Sciences 24:2, pages 1701.
Crossref
Mona Sadeghalvad, Amir Hossein Mansourabadi, Maryam Noori, Seyed Aria Nejadghaderi, Masoomeh Masoomikarimi, Masoumeh Alimohammadi & Nima Rezaei. (2022) Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies. Reviews in Medical Virology 33:1.
Crossref
Qiaren He, Shiyu Sun, Xi Chen, Zhenxiang Hu, Yan Zhang, Hua Peng, Yang-Xin Fu, Jiaming Yang & Long Chen. (2022) The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages. Journal of Clinical Medicine 12:1, pages 146.
Crossref
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, Alexander Jarde, Silvia Minozzi, Hanna Bergman, Brian S Buckley, Katrin Probyn, Gemma Villanueva, Nicholas Henschke, Hillary Bonnet, Rouba Assi, Sonia Menon, Melanie Marti, Declan Devane, Patrick Mallon, Jean-Daniel Lelievre, Lisa M Askie, Tamara Kredo, Gabriel Ferrand, Mauricia Davidson, Carolina Riveros, David Tovey, Joerg J Meerpohl, Giacomo Grasselli, Gabriel Rada, Asbjørn Hróbjartsson, Philippe Ravaud, Anna Chaimani & Isabelle Boutron. (2022) Efficacy and safety of COVID-19 vaccines. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, Aryan Aarabi, Zahra Payandeh & Masoumeh Rajabibazl. (2022) An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cellular & Molecular Biology Letters 27:1.
Crossref
Matteo Castaldo, Marta Waliszewska-Prosół, Maria Koutsokera, Micaela Robotti, Marcin Straburzyński, Loukia Apostolakopoulou, Mariarita Capizzi, Oneda Çibuku, Fidel Dominique Festin Ambat, Ilaria Frattale, Zukhra Gadzhieva, Erica Gallo, Anna Gryglas-Dworak, Gleni Halili, Asel Jusupova, Yana Koperskaya, Alo-Rainer Leheste, Maria Laura Manzo, Andrea Marcinnò, Antonio Marino, Petr Mikulenka, Bee Eng Ong, Burcu Polat, Zvonimir Popovic, Eduardo Rivera-Mancilla, Adina Maria Roceanu, Eleonora Rollo, Marina Romozzi, Claudia Ruscitto, Fabrizio Scotto di Clemente, Sebastian Strauss, Valentina Taranta, Maria Terhart, Iryna Tychenko, Simone Vigneri, Blazej Misiak, Paolo Martelletti & Alberto Raggi. (2022) Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. The Journal of Headache and Pain 23:1.
Crossref
Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi, Chankyu Lee, Jeong-Yoon Lee, Kazutoyo Miura, Wei-Chiao Huang, Young-Shin Park, Sun-Je Woo, Sang Hwan Seo, Jae-Ouk Kim, Manki Song, Chung-Jong Kim, Jae-Ki Choi, Jieun Kim, Eun Ju Choo & Jung-Hyun Choi. (2022) Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine. BMC Medicine 20:1.
Crossref
Bingyi Yang, Xiaotong Huang, Huizhi Gao, Nancy H. Leung, Tim K. Tsang & Benjamin J. Cowling. (2022) Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis. BMC Medicine 20:1.
Crossref
Zejun Li, Shouhuan Liu, Fengming Li, Yifeng Li, Yilin Li, Pu Peng, Sai Li, Li He & Tieqiao Liu. (2022) Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Liqing Chen, Xiaoxiao Qi, Dan Liang, Guiqi Li, Xiaofang Peng, Xiaohui Li, Bixia Ke, Huanying Zheng, Zhongqiu Liu, Changwen Ke, Guochao Liao, Liang Liu & Qian Feng. (2022) Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants. Vaccines 10:9, pages 1502.
Crossref
Amir Ghaemi, Parisa Roshani Asl, Hedieh Zargaran, Delaram Ahmadi, Asim Ali Hashimi, Elahe Abdolalipour, Sahar Bathaeian & Seyed Mohammad Miri. (2022) Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity. Frontiers in Immunology 13.
Crossref
Ahmad A. Toubasi, Thuraya N. Al‐Sayegh, Yazan Y. Obaid, Sarah M. Al‐Harasis & Saif Aldeen S. AlRyalat. (2022) Efficacy and safety of COVID‐19 vaccines: A network meta‐analysis. Journal of Evidence-Based Medicine 15:3, pages 245-262.
Crossref
Zhiren Zhang, Qiaren He, Wei Zhao, Yong Li, Jiaming Yang, Zhenxiang Hu, Xi Chen, Hua Peng, Yang-Xin Fu, Long Chen & Ligong Lu. (2022) A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron Strains. Journal of Clinical Medicine 11:14, pages 4164.
Crossref
Manoj Kumar, Meenu Mariya James, Manoj Kumawat, Bilkees Nabi, Poonam Sharma, Namrata Pal, Swasti Shubham, Rajnarayan R. Tiwari, Devojit Kumar Sarma & Ravinder Nagpal. (2022) Aging and Microbiome in the Modulation of Vaccine Efficacy. Biomedicines 10:7, pages 1545.
Crossref
Farnoosh Seirafianpour, Homa Pourriyahi, Milad Gholizadeh Mesgarha, Arash Pour Mohammad, Zoha Shaka & Azadeh Goodarzi. (2022) A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated dermatologic disorders. Dermatologic Therapy 35:6.
Crossref
Ye Zhang, Ruixin Wang, Chunyan He, Yu-Fang Zhang, Zhongrui Luo, Jia Luo, Sisi Chen, Yu Jin, Bowen Xie & Ye Liu. (2022) Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains. Nano Today 43, pages 101393.
Crossref
Cindra Tri Yuniar, Bhekti Pratiwi, Ardika Fajrul Ihsan, Bambang Tri Laksono, Iffa Risfayanti, Annisa Fathadina, Yeonseon Jeong & Eunyoung Kim. (2022) Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review. Vaccines 10:2, pages 313.
Crossref
Gatot Soegiarto, Jonny Karunia Fajar, Laksmi Wulandari, Muhammad Anshory, Muhammad Ilmawan, Anisa Asmiragani, Himma Illiyana, Azaria Adam, Sutini Lamadi, Umi Sa'adah, Tubagus Yuantoko, Esi Nanda, Farida Rachmawati, Nabila Rahmadani, Randy Talilah, Madyline Katipana, Sharon Susanto, Maria Hindom, Ufi Anjasari, Nur Hidayah, Nanda Fadilla, Vanela Lekatompessy, Uzi Phoenna, Fredo Tamara, Dessy Aprilia Kartini, Aditya Indra Mahendra, Andi Permana, Erwin Alexander Pasaribu, Kuldeep Dhama & Harapan Harapan. (2022) Seroconversion rates among different designs of COVID-19 vaccines: a network meta-analysis of randomized controlled trials. F1000Research 11, pages 299.
Crossref
Shiyu Sun, Xi Chen, Jingjing Lin, Junwen Ai, Jiaming Yang, Zhenxiang Hu, Yang-Xin Fu & Hua Peng. (2021) Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01. Cell Discovery 7:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.